Skip to main content
Premium Trial:

Request an Annual Quote

Japanese Pharma Licenses ChemAxon Software for Drug R&D

Premium

ChemAxon said this week that Eisai, a Japanese pharmaceutical company, has licensed one of its cheminformatics packages through its distributor Patcore, an informatics services company based in Japan.

Specifically, Eisai will use ChemAxon's JChem Cartridge, a chemical database management and search tool, to manage the compound structure information it generates in its drug discovery efforts, ChemAxon said.

JChem Cartridge will be used alongside a compound control checking system developed by Patcore called CRAIS Checker, which evaluates chemical structures to determine whether compounds are controlled substances.

In December, ChemAxon announced that it had moved its headquarters to a larger office in its hometown of Budapest, Hungary. The company said that the move would help it better meet the needs of its growing customer base as well as house existing staff and new hires (BI 12/9/2011).

Shortly afterwards, ChemAxon said that it would be working along with its partner Linguamatics on a €671,000 ($870,000) EU-funded project, dubbed Chemically Informed Knowledge Extraction from Literature, or ChiKEL, that aims to develop text-mining software for chemical research (BI 12/16/2011).

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.